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Retinal pigment epitheliumRetinal pigment epithelium (RPE) plays a major role in the maintenance of photoreceptors, and degeneration of
RPE results in the development of age-related macular degeneration (AMD). Accumulation of intracellular pro-
tein aggregates, increased oxidative stress, and chronic inﬂammation are all factors damaging the functionality
of aged RPE cells. Here, we report that inhibition of proteasomal degradation with MG-132 and autophagy
with baﬁlomycin A1 resulted in the release of IL-1β but not that of IL-18 in human ARPE-19 cells. NLRP3 receptor
became upregulated, and caspase-1, the functional component of an inﬂammasome complex, was activated. In
addition to accumulating intracellular protein aggregates, inhibition of degradation systems induced oxidative
stress which was demonstrated by elevated amounts of intracellular 4-hydroxynonenal (HNE)-protein adducts.
Along with IL-1β, exposure to MG-132 and baﬁlomycin A1 resulted in the secretion of IL-8. A low concentration
(1 pg/ml) of IL-1β was capable of triggering signiﬁcant IL-8 production which also became attenuated by treat-
ment with a speciﬁc caspase-1 inhibitor. These results suggest that decline in intracellular degradation systems
results not only in increased amounts of intracellular protein aggregates and oxidative stress but also in the
activation of NLRP3 inﬂammasomes, arisen as a result of elevated production of biologically active IL-1β.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Retinal pigment epithelium (RPE) is a single-cell layer of post-
mitotic cells, which performs many important functions in the human
retina. RPE cells play a crucial role in maintaining the function of photo-
receptor cells by ingesting and degrading the spent tips of photorecep-
tor outer segments (POS) and by providing photopigments to rods and
cones [1–3]. RPE cells also transport nutrients and waste products
between the sensory retina and choroid layers, protect the outer retina
from light-generated oxygen reactive species (ROS), and take responsi-
bility for the immune defense of macula [2,4]. Due to their extremely
active metabolism, high oxygen consumption, and prolonged exposure
to light RPE cells are subjected to high levels of oxidative stress [5]. Ox-
idative stress, concurrently with the age-related decrease in antioxidantn; BafA, Baﬁlomycin A; HNE, 4-
tinal pigment epithelium
lmology, Institute of Clinical
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.production, disturbs homeostatic regulation by RPE, and contributes to
the accumulation of aggregates by oxidizing cellular macromolecules
[3]. Moreover, age-related accumulation of nondegradable lipofuscin
in the lysosomes of RPE cells disturbs the degradation of waste material
and agedmitochondria resulting in the increased production of reactive
oxygen species (ROS) [6]. Since lipofuscin is a photoinducible material,
it can accelerate oxidative stress also by itself [6]. Lipofuscin contains
lipid peroxidation- or glucoxidation-induced end products 4-
hydroxynonenal (HNE), malondialdehyde (MDA), and advanced
glycation end products (AGEs) which have been associated with de-
creased proteolysis, inﬂammation, and RPE degeneration [7]. A dysfunc-
tion of RPE cells is the primary event leading to the photoreceptor
damage, loss of vision, and the clinically observed changes encountered
in AMD [8].
Autophagy and the ubiquitin-proteasome pathway (UPP) are two
central degradation systems in mammalian cells [9]. UPP plays a key
role in eliminating short-lived and misfolded proteins that cannot be
repaired by chaperones. Autophagy is a specialized process for eliminat-
ing long-lived proteins, protein aggregates and cell organelles [9]. In the
ﬁnal phase of autophagy, the cargo of autophagosomes is digested by
lysosomal hydrolases [10]. When degradation systems are functioning
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adverse effects, such as increased oxidative stress, and tightly controlled
cellular functions, e.g. proliferation, cell survival and signal transduction
progress without disturbance. However, both proteasomal and
autophagosomal degradation are known to decline in aged RPE cells
[11,12].
It has been shown recently that autophagy is capable of regulating
inﬂammasomes, and it probably inhibits the intracellular signaling by
removing dysfunctional mitochondria that would otherwise produce
increased amounts of ROS [13,14]. Furthermore, cytosolic mtDNA can
contribute to inﬂammasome activation [13–15]. Inﬂammasomes are in-
tracellular protein complexes that play a major role in the induction of
inﬂammation. Currently, the best-known inﬂammasomes are those
having NLRP3 (Nucleotide-binding domain and Leucine rich repeat
Receptor containing a Pyrin domain 3) as their receptor component.
The activation of NLRP3 inﬂammasomes is a two-step process. The
priming signal can come either through TLR (Toll-like receptor) or cyto-
kine receptors, and this results in the production of NLRP3 protein and
the inactive pro-forms of proinﬂammatory cytokines IL-1β and IL-18
[16,17]. Oligomerization of NLRP3 after sensing its activator enables
the complex to recruit the adaptor protein ASC (apoptosis-associated
speck-like protein containing caspase recruitment domain [CARD])
and pro-caspase-1 to the complex, which results into autoactivation of
the enzyme. Thereafter, activated caspase-1 is able to process pro-
forms of IL-1β and IL-18 into their mature and secreted forms. Lately,
several research groups have linked the activation of NLRP3
inﬂammasomes to RPE degeneration and AMD pathogenesis [18–20].
In the present study, we have explored the effect of dysfunctional
degradation machinery in RPE cells on inﬂammasome signaling. We in-
duced intracellular protein aggregates in human ARPE-19 cells by
inhibiting proteasomal degradation with MG-132, and prevented the
autophagy-mediated clearance of aggregates by neutralizing lysosomal
enzymeswith the antibiotic, baﬁlomycin A1. Thereafter, we determined
inﬂammasome activity. Our data suggest that decline in intracellular
degradation systems is capable of inducing inﬂammasome signaling
and increasing the secretion of IL-1β without elevating the production
of IL-18. Particularly low instead of high intracellular amounts of HNE-
protein adducts seem to favor IL-1β release over IL-18. Inﬂammasome
activation with IL-1β liberation also shows biological relevance in its
capability to induce the production of IL-8.
2. Materials and methods
2.1. Cells and stimulations
ARPE-19 cells were purchased from the American Type Culture
Collection (ATCC). Cells were cultivated in a humidiﬁed 10% CO2 atmo-
sphere at 37 °C in Dulbecco's MEM/Nut MIX F-12 (1:1) medium (Life
Technologies, Paisley, UK) containing 10% inactivated fetal bovine
serum (Hyclone, Logan, UT, USA), 100 units/ml penicillin (Cambrex,
Charles City, IA, USA), 100 μg/ml streptomycin (Cambrex), and
2 mM L-glutamine (Life Technologies). Conﬂuent cell cultures were
washed with serum-free DMEM/F12 medium and stimulated with
MG-132 (5 μM; Calbiochem, San Diego, CA) in the serum-free medium
for 24 h in a humidiﬁed 10% CO2 atmosphere at 37 °C. After incubation,
the cells were further stimulated with baﬁlomycin A1 (50 nM; Sigma-
Aldrich, Steinheim, Germany) in fresh serum-freemedium. The samples
were collected after 24 h incubation in a humidiﬁed 10% CO2 atmo-
sphere at 37 °C. Cell cultures were also treated with irreversible
caspase-1 inhibitor (20 μM; caspase-1 inhibitor II, Ac-YVAD-CMK,
Calbiochem, San Diego, CA) prior to both MG-132 and baﬁlomycin A1
stimulations where indicated. Both MG-132 and baﬁlomycin A1 were
solubilized in DMSO, which alone did not induce any signiﬁcant release
of cytokines nor did treatment with a caspase-1 inhibitor alone (data
not shown). In addition, we tested boosting of inﬂammasome priming
by stimulating cells with lipopolysaccharide (LPS, 10 μg/ml; Sigma)for 24 h in a humidiﬁed 10% CO2 atmosphere at 37 °C before the expo-
sure to MG-132. Where indicated, cells were also stimulated with re-
combinant human (rh)IL-1β (1 pg/ml; Life Technologies, Paisley, UK)
or by different concentrations of 4-hydroxynonenal (HNE) for 24 h in
a humidiﬁed 10% CO2 atmosphere at 37 °C.
2.2. Sample preparation
Medium samples and cell lysates were collected 24 h after the
baﬁlomycin A1 treatment. Cells were rinsed with 1× DPBS (Dulbecco's
phosphate buffered saline, Lonza Group Ltd., Switzerland) before lysis
with M-PER solution (Thermo Scientiﬁc, Waltham, MA, USA) for West-
ern blot analyses andwith the cell lysis buffer provided by Cell Signaling
Technologies (Danvers, MA, USA) for ELISA measurements. Cell lysates
were centrifuged, and the supernatants were transferred to clean
tubes. In the caspase-1 activity assays, lysis buffer was provided by the
manufacturer (R&D Systems, Minneapolis, MN, USA). The lysates for
ELISA assays were sonicated 3 × 10 s. Both medium samples and cell
lysates were stored at−70 °C until analyzed.
2.3. ELISA measurements
Concentrations of pro-inﬂammatory cytokines IL-1β, IL-6, and IL-8
were determined using commercial enzyme-linked immunosorbent
assay (ELISA) reagents (BD Pharmingen, San Jose, CA, USA). IL-1β was
also measured using a high-sensitive ELISA kit (eBioscience, San
Diego, CA, USA), according to the manufacturer's protocol. Since IL-1β
ELISA assays do not commonly specify, whether they measure only
themature cytokine or also the inactive pro-form, an ELISA kit designed
speciﬁcally to detect pro-IL-1β (R&D Systems, United Kingdom) was
also used. Additionally, concentrations of IL-18 and NLRP3 were mea-
sured using commercial ELISA kits (eBioscience, San Diego, CA, USA
and Cusabio, Wuhan, China, respectively). Since IL-18 was not detected,
the result was veriﬁed using an ELISA kit from another manufacturer
(MBL International).
2.4. Caspase-1 activity assay
Caspase-1 activity was measured from cell lysates using a commer-
cial kit from R&D Systems according to the manufacturer's protocol.
Results were normalized to protein concentrations measured by the
Bradford method [21] from cell lysates.
2.5. Cell viability assay
In order to determine the integrity of the cellular membrane, the
amount of lactate dehydrogenase (LDH) was measured from medium
samples with a commercial kit (Promega Corporation, Madison, WI,
USA) according to the manufacturer's protocol.
2.6. Western blot assays
For detecting pro-caspase 1, whole 20 μg of protein in cell lysates
were run in 15% SDS-PAGE gels and then wet-blotted onto nitrocellu-
lose membranes (Amersham, Pittsburgh, PA, USA). Transfer of proteins
from gels to membranes was ensured by staining with Ponceau S
(Sigma-Aldrich, St. Louis, MO, USA). The membranes were blocked
overnight in 5% fat-free milk in 0.1% Tween-20/Tris buffered saline
(TBS; 50 mM Tris, 150 mM NaCl) at +4 °C. The blocking buffer was
also used as a washing buffer and a diluent of primary and secondary
antibodies. Thereafter, the membranes were incubated for 2 h at RT
with a rabbit monoclonal caspase-1 antibody (1:1000; Cell Signaling
Technologies). After washing four times for 10 min, the membranes
were incubated for 1 h at RT with horseradish peroxidase-conjugated
anti-rabbit IgG antibody (1:10,000; GE Healthcare, Little Chalfont,
Buckinghamshire, UK). The membranes were washed before detection
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an enhanced chemiluminescent assay for horseradish peroxidase
(Millipore, Billerica, MA, USA), and normalized to α-tubulin values
using mouse monoclonal α-tubulin (Sigma-Aldrich, St. Louis, MO,
USA) and polyclonal HRP-conjugated sheep anti-mouse IgG (GE
Healthcare Life Sciences) antibodies. The results were quantiﬁed using
the ImageJ program (http://rsb.info.nih.gov/ij/index.html).
HNE was detected by loading 10–20 μg of protein in cell lysates to
12.5% SDS-PAGE gels. After electrophoresis, proteins were wet-blotted
to nitrocellulose membranes (Millipore, Bedford, MA, USA). Equal
transfer was checked as described above. After blocking in 5% fat-free
milk solution for 60 min at 37 °C, the membranes were treated with a
rabbit monoclonal HNE (Alpha Diagnostics, San Antonio, TX, USA) and
DyLight 800-conjugated goat anti-rabbit IgG antibodies (Thermo Scien-
tiﬁc, Rockford, IL, USA) as described previously by Oksala et al. [22]. The
results were normalized to β-actin (Sigma) values using mouse mono-
clonal β-actin (Sigma) and DyLight 800-conjugated goat anti-mouse
IgG antibodies. Immunoblots were visualized with an Odyssey imaging
system (Li-Cor Biosciences Inc., Lincoln, NB, USA) and quantiﬁed using
the Odyssey Software.
2.7. NLRP3 siRNA treatments
ARPE-19 cells at 60–80% conﬂuencywerewashedwith freshDMEM/
F12 medium and treated with Silencer Select siRNA (ID: s41556;
Ambion by Life Technologies, Europe BV) targeting the NLRP3 gene
using Lipofectamine® RNAiMAX Transfection Reagent (Invitrogen by
Life Technologies) according to themanufacturer's instructions. Silencer
Select Negative Control siRNA and Silencer Select GAPDH siRNA served
as negative and positive controls, respectively. Following the 24 h trans-
fection, cells were treated with MG-132 and baﬁlomycin A1 as previ-
ously described. Total RNA was extracted from cells using the Illustra
RNAspin Mini Kit (GE Healthcare Life Sciences).
2.8. Real-time PCR
Total RNA was reverse-transcribed to cDNA using SuperScriptTM III
First-Strand Synthesis System for RT-PCR (Invitrogen by Life Technolo-
gies Europe BV). The expression of human GAPDH and human NLRP3
RNAswas studiedwith the Applied Biosystems 7500 Real Time PCR Sys-
tem (Applied Biosystems by Life Technologies Europe BV) using SYBR®
Green chemistry (Applied Biosystems). The primers purchased from
TAG Copenhagen (Copenhagen, Denmark) were forward 5′-CGAGAT
CCCTCCAAAATCAA-3′ and reverse 5′-GGTGCTAAGCAGTTGGTGGT-3′
for GAPDH, and forward 5′-GGCATATCACAGTGGGATTC-3′ and reverse
5′-GATCTTCGCTGCGATCAAC-3′ for NLRP3. The thermo-cycling pro-
gram consisted of 40 cycles at 95 °C for 15 s and at 60 °C for 60 s with
an initial cycle at 95 °C for 10 min. The melting curve analysis was
performed over the range of 60–95 °C. cDNA was semi-quantiﬁed and
analyzed using the ΔΔCt (change in cycle threshold, Ct) method.
2.9. Statistical analysis
Statistical analyses were conducted using GraphPad Prism
(Graphpad Software, San Diego, CA). Pairwise comparisons between
independent groups were assessed using the Mann–Whitney U-test.
Results are presented as mean ± standard error of means (SEM), and
P-values of 0.05 or less were considered statistically signiﬁcant.
3. Results
3.1. Intracellular protein aggregates induce IL-1β but not IL-18 secretion in
ARPE-19 cells
In order to study the ability of dysfunctional intracellular degrada-
tion to activate the inﬂammasome signaling, ARPE-19 cells wereexposed to the proteasome inhibitor, MG-132, for 24 h. Viiri et al.
have recently shown that MG-132 treatment induces the accumulation
of intracellular aggregates in those cells and under normal conditions,
autophagy will clean the aggregates away [23]. In addition to
proteasomal inhibition, we therefore exposed our cells to baﬁlomycin
A1 for another 24 h in order to block autophagy. As shown in Fig. 1,
MG-132 induced a slight but detectable increase in the release of
inﬂammasome-related cytokine IL-1β. The increasewas not statistically
signiﬁcant until the subsequent treatment with baﬁlomycin A1, which
blocked autophagy (Fig. 1). Meanwhile, no increase was observed in
the production of IL-18. Due to the low concentrations, the IL-1β pro-
duction was conﬁrmed from three independent experiments also
using a high-sensitivity ELISA kit from another manufacturer (e-Biosci-
ence), and the results were similar as those obtained with the ELISA kit
(Becton Dickinson) routinely used in our laboratory (data not shown).
Moreover, in order to boost the priming of inﬂammasome signaling,
cells were pretreated with LPS (10 μg/ml) before the exposure to MG-
132 and baﬁlomycin A1. The proﬁle of IL-1β production remained sim-
ilar, LPS priming only resulted in slightly higher IL-1β concentrations.
The highest IL-1β concentrations measured using LPS + MG-132 and
LPS + MG-132 + baﬁlomycin A1 were 1.31 ± 0.16 and 2.6 ±
0.14 pg/ml (mean ± SEM), respectively, whereas control cells and
those treated with LPS alone did not produce any measurable levels of
IL-1β. Statistical signiﬁcances were P b 0.01** between both control
vs. LPS + MG-132, and control vs. LPS + MG-132 + baﬁlomycin A1
(Mann–Whitney U-test).
3.2. MG-132 + baﬁlomycin A1 treatment releases mature IL-1β instead of
inactive pro-form of the cytokine
Proteasome inhibitor MG-132 with baﬁlomycin A1 is a robust treat-
ment compromising cell membrane integrity. This can be observed as
an increased release of LDH enzyme to the culturemedium. In these ex-
periments, ARPE-19 cells tolerated baﬁlomycin A1 much better than
MG-132 but when baﬁlomycin A1 was added after exposure to MG-
132, the combined effect was evenmore pronounced than that induced
by MG-132 alone (Fig. 2).
In order to ensure that the IL-1β beingmeasured frommedium sam-
ples was not inactive pro-IL-1βwhich had leaked out of the cells due to
ruptured cell membranes, we measured the concentration of pro-IL-1β
from both cell lysates and the medium samples. As shown in Fig. 3 (left
panel), there was no signiﬁcant difference in the amount of pro-IL-1β
between groups in the medium or lysate samples. This is important
since when the mature cytokine is concerned, MG-132 + baﬁlomycin
A1 greatly and signiﬁcantly increased the amount of secreted IL-1β
when compared to control cell mediums (Fig. 3, right panel). In cell
lysates, MG-132 + baﬁlomycin A1 did not signiﬁcantly increase the
concentration of mature IL-1β (Fig. 3, right panel).
3.3. IL-1β secretion is associated with the inﬂammasome activation
In order to study the association of inﬂammasome activation with
increased IL-1β secretion in ARPE-19 cells, we measured the caspase-1
activity from cell lysates. As shown in Fig. 4A, MG-132 + baﬁlomycin
A1 treatment signiﬁcantly increased the caspase-1 activity. Treatment
with the inhibitor alone or DMSO did not have any signiﬁcant effect
on caspase-1 activity (data not shown). When the function of
caspase-1 was inhibited with a speciﬁc inhibitor, MG-132 and
baﬁlomycin A1-mediated IL-1β secretion was signiﬁcantly reduced
(Fig. 4B). Concurrently with the caspase-1 activation, there was
also a signiﬁcant decrease in the intracellular concentrations of
pro-caspase-1 (Fig. 4C).
It has been convincingly shown that NLRP3 inﬂammasome activa-
tion can take place in ARPE-19 cells [18–20,24,25], and therefore, we
studied the expression of inducible NLRP3 protein in our current sam-
ples. These results show that there was a signiﬁcant increase in the
Fig. 1. Production of inﬂammasome-related cytokines byMG-132 and baﬁlomycin A1 (BafA). ARPE-19 cellswere treatedwith 5 μMMG-132 for 24h and exposed to 50nMbaﬁlomycin A1
for another 24 h. Untreated cells plated at same numbers and grown under similar conditions served as controls. Identical volumes of culture medium samples were taken and IL-1β and
IL-18 cytokines were measured with an ELISA technique. Results are presented as mean± SEM of six parallel samples/group, and they are representative of nine (IL-1β) and ﬁve (IL-18)
independent experiments. **P b 0.01, ns = not signiﬁcant, Mann–Whitney U-test.
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baﬁlomycin A1 when compared to controls (Fig. 5A). Expression of
MG-132 + baﬁlomycin A1-induced NLRP3 was inhibited by speciﬁc
siRNAs (Fig. 5B).
3.4. MG-132 induces the production of HNE in ARPE-19 cells
We have previously shown that HNE is able to induce NLRP3
inﬂammasome signaling in ARPE-19 cells, and therefore we measured
intracellular amounts of HNE-protein adducts. As shown in Fig. 6A,
MG-132 signiﬁcantly increased the amount of HNE-protein adducts in
ARPE-19 cells. The effect of baﬁlomycin A1 was also statistically signiﬁ-
cant but much weaker than that of MG-132. When administered to-
gether, however, an additive effect was apparent (Fig. 6A). In
comparison, our previous treatment of ARPE-19 cells with 30 μM HNE,
induced three to four times higher amounts of intracellular HNE-
protein adducts than could be obtained with MG-132 + baﬁlomycin
A1 (Fig. 6B). LPS used for the priming of inﬂammasome signaling did
not markedly change the effect of HNE (Fig. 6B). When the cells were
treated with different concentrations of HNE, there was a clear trendFig. 2. Effect of MG-132 and baﬁlomycin A1 (BafA) treatments on cellular viability asmea-
sured by the release of LDH. Enzyme levels were measured frommedium samples using a
commercial kit after exposing cells consecutively to MG-132 for 24 h and then to
baﬁlomycin A1 for 24 h where indicated. Data were normalized to protein concentrations
and compared to control values. Results are shown asmean±SEMof six parallel samples/
group, and they are representative of four (MG-132 and baﬁlomycin A1 alone) and six
(MG-132 + baﬁlomycin A1) independent experiments. *P b 0.05, **P b 0.01, ns = not
signiﬁcant, Mann–Whitney U-test.in the release of higher amounts of IL-1β by the lower HNE concentra-
tions 1 and 5 μM when compared to higher concentrations 15 and
30 μM (Fig. 7).3.5. IL-8 production induced by MG-132 can be secondary to IL-1β release
In addition to inﬂammasome-related cytokines, we measured the
production of two other pro-inﬂammatory mediators, i.e. IL-6 and
IL-8. We observed that MG-132 + baﬁlomycin A1 increased the pro-
duction of IL-8 but not that of IL-6 (Fig. 8). Moreover, the production
of IL-8 by MG-132 + baﬁlomycin A1 declined when the cells were
treated with the speciﬁc caspase-1 inhibitor prior to stimulation
(Fig. 8). Caspase-1 inhibitor had no inﬂuence on the production of IL-6
(Fig. 8). As presented in Fig. 9, IL-1β at the concentration of 1 pg/ml
signiﬁcantly increased the IL-8 production. The whole pathway from a
decline in degradation systems up to IL-8 production is shown in aFig. 3. Concentrations of pro (left panel) andmature (right panel) IL-1β inside and outside
of the cell. ARPE-19 cells were treated with MG-132 (24 h) and baﬁlomycin A1 (BafA,
24 h), and both medium and cell lysate samples were collected. pro and mature forms
of IL-1βwere measured using ELISA. Data are combined from three independent experi-
ments with six parallel samples in each group/experiment. IL-1β has been measured
using a highly sensitive IL-1β kit. The results are presented as mean ± SEM. *P b 0.05,
***P b 0.001, ns = not signiﬁcant, Mann–Whitney U-test.
Fig. 4.Activity of caspase-1 following theMG-132 and baﬁlomycin A1 (BafA) treatments. Cells were treated ﬁrst withMG-132 for 24 h and thenwith baﬁlomycin A1 for another 24 h. The
caspase-1 inhibitor (20 μM)was added prior to each treatment where indicated. Medium samples and cell lysates were collected for analyses. (A) Caspase-1 activity measured from the
cell lysates using a commercial kit. Data are combined from four independent experiments with two parallel samples in each group/experiment. (B) Effect of caspase-1 inhibitor on the
production of IL-1β byMG-132+ baﬁlomycinA1. Resultsmeasured frommedium samples by ELISA are representative of three independent experimentswith six parallel samples/group.
(C) Amount of pro-caspase-1 in cell lysates. The pro-enzyme concentrationwasmeasuredusing theWestern blot technique, and a representative blot picture is shown.Densitometric data
are combined from two independent analyseswith four parallel samples/group. All data in bar graphs are presented asmean±SEM. *P b 0.05, **P b 0.01, ***P b 0.001, ns=not signiﬁcant,
Mann–Whitney U-test.
Fig. 5. Effect of MG-132 and baﬁlomycin A1 (BafA) on the NLRP3 expression. (A) Cells were treated with MG-132 and baﬁlomycin A1 for 24 h each, and culture medium samples were
analyzed for the level of NLRP3 protein using ELISA. Results are representative of three independent experiments with six parallel samples/group. (B) siRNA treatment (24 h) preceded
the exposures toMG-132 andbaﬁlomycinA and thereafter, the expression of NLRP3was determined using qPCR. Data are combined from two independent experimentswith four parallel
samples in each group/experiment. Results are presented as mean ± SEM. *P b 0.05, Mann–Whitney U-test.
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Fig. 6. Effects of (A)MG-132+ baﬁlomycin A1 (BafA), and (B) LPS+HNE treatments on the formation of HNE-protein adducts in ARPE-19 cells. Each of theMG-132, baﬁlomycin A1, LPS,
and HNE treatments on ARPE-19 cells lasted 24 h. Intracellular HNE-protein adducts were measured from cell lysates by the Western blot method, and a representative blot picture is
shown. The antibody used in this study detects 4-HNE histidine adducts and therefore, it quite speciﬁcally labels the protein most sensitive to histidine-bound HNE. Densitometric data
are combined from three independent experiments with two parallel samples in each group/experiment. The results are presented as mean ± SEM. **P b 0.01, Mann–Whitney U-test.
3043N. Piippo et al. / Biochimica et Biophysica Acta 1843 (2014) 3038–3046schematic summary of the effects of MG-132 + baﬁlomycin A1 on
human ARPE-19 cells (Fig. 10).4. Discussion
There aremany distinct age-related events that can disrupt the func-
tion of RPE cells contributing to the vision loss diagnosed as AMD. Both
proteasomal degradation and autophagy activity become reduced
which results in the accumulation of intracellularwastematerial, oxida-
tive stress, and inﬂammation [11,12,23]. Lysosomal rupture is known to
be a potent player in the activation of inﬂammasome signaling [26].
With respect to autophagy, lysosomal damage could be a possiblemedi-
ator but in the present study, neutralization of the lysosomal enzymes
by baﬁlomycin A1 blockade did not prevent the activation ofFig. 7. IL-1β production in response to different HNE concentrations. Cells were primed
with 10 μM LPS, and exposed to different concentrations of HNE. Medium samples were
collected and concentrations of IL-1βmeasured with an ELISA method. The data are com-
bined from four independent experiments with 4–17 parallel samples in each group. The
results are presented asmean±SEM. **P b 0.01, ***P b 0.001, ns=not signiﬁcant,Mann–
Whitney U-test.inﬂammasomes even though it removed the possibility of cathepsin B
to contribute to the activation process. The increased amounts of pro-
tein aggregates and the presence of dysfunctional mitochondria evoke
excessive oxidative stress that is one of the most prominent inducers
of inﬂammasome signaling [12]. It has even been suggested that all of
the various NLRP3 activators induce some kind of oxidative stress,
which could act as a commonmediator in the inﬂammasome activation
[27–30]. We have previously shown that oxidative stress is capable
of inducing NLRP3-mediated inﬂammasome signaling in human
ARPE-19 cells [18]. In the present study, we examined the effect of
degenerated intracellular clearance on the induction of inﬂammasome
signaling.
After inducing intracellular protein aggregation by inhibiting
proteasomes using MG-132, we observed a small but detectable in-
crease in the release of IL-1β. It has recently been shown that autophagy
eliminates the intracellular protein aggregates induced by MG-132 in
ARPE-19 cells [23]. Since our cells were not aged or derived from AMD
patients, it is probable that their fully functional autophagy degraded
the aggregates as rapidly as they were being produced by MG-132,
and thus reduced the ability of protein aggregates to induce severe
inﬂammasome activation. When inhibiting also autophagy by
baﬁlomycin A1, the release of IL-1β was signiﬁcantly increased. The
low levels of IL-1β were not surprising since it is known to be a very
powerful cytokine under very strict regulation [31]. The cytokine secret-
ed into extracellular space may rapidly bind to cell surface receptors,
soluble receptors, or receptor antagonists, which increases challenge
in its measurement from medium samples. Moreover, our protocol to
perform experiments in serum-freemediummost probably contributes
to the low IL-1β levels detected. Due to its resilience, ARPE-19 cell line is
a good study model to be used without bovine-derived material, which
could contribute to cell responses or provide non-speciﬁc background in
measurements. According to our experience, ARPE-19 cells could
manage up to 1 week with nutrients included in the serum-free
basal medium. Despite the fact that the speciﬁc increase of IL-1β by
MG-132 + baﬁlomycin A1 was repeated several times in our experi-
ments, nonetheless we conﬁrmed the increased IL-1β production by
using a highly-sensitive ELISA kit from another manufacturer. In addi-
tion, we tested the effect of LPS priming prior to exposure to MG-132
and baﬁlomycin A1. LPS priming enhanced the IL-1β production but
did not change the secretion proﬁle, which further proved that the
Fig. 8. Productions of (A) IL-8 and (B) IL-6 byMG-132 and baﬁlomycinA1 (BafA), and the effect of caspase-1 inhibitor on them. Cellswere treatedwithMG-132 for 24h and baﬁlomycinA1
for 24 h, and a speciﬁc caspase-1 inhibitorwas added prior to treatments where indicated. Results are presented asmean± SEM of six parallel samples/group, and they are representative
of three independent experiments. **P b 0.01, ns = not signiﬁcant, Mann–Whitney U-test.
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to prime the inﬂammasome signaling, we did not want to involve LPS
in our later experiments with MG-132 and baﬁlomycin A1.
MG-132 + baﬁlomycin A1 treatment signiﬁcantly increased the
amount of LDH in the culture medium which indicates that the treat-
ment compromised the integrity of cell membranes. Our results do
not exclude pyroptosis, a caspase-1-mediated cell death, but only
shows that cell membranes become ruptured. In this study, the mecha-
nismwas purposely left secondary sinceweweremore interested in the
form of IL-1βmeasured from our medium samples. Therefore, in addi-
tion to IL-1βmeasured with common ELISA kits which do not necessar-
ily rule out the inactive pro-form, we analyzed the amount of pro-IL-1β
from both cell lysate andmedium samples with a speciﬁc ELISA kit. The
concentrations of both pro andmature IL-1βwere higher in lysates than
in medium samples, and the ﬁnding was applicable to both control and
treatment groups. Theremay be several reasons for this phenomenon. It
is probable thatmore pro-IL-1β is found in lysates since it should not be
actively released outside of the cell. Instead, the mature IL-1β in lysate
samplesmay result from binding of the cytokine to its speciﬁc receptors
on the cell surface. In the preliminary experiments conducted for our
previous article [18], we found that the exposure to the IL-1 receptor an-
tagonist before inﬂammasome activation by HNE evoked a moreFig. 9.Ability of IL-1β to induce the production of IL-8. Cells were exposed to recombinant
human IL-1β (1 pg/ml) for 24 h, and concentrations of IL-8 were measured frommedium
samples. The data are combined from three independent experiments with six parallel
samples in each group/experiment. The results are shown as mean ± SEM. ***P b 0.001,
Mann–Whitney U-test.consistently increased secretion of IL-1β. Since there was no signiﬁcant
difference in the amount of pro-IL-1β between groups in themediumor
lysate samples, andMG-132+ baﬁlomycin A1 greatly and signiﬁcantly
increased the amount of secreted IL-1β when compared to control
cell mediums, we can infer that IL-1β measured from our present
medium samples, was a mature form of the cytokine. Moreover,
MG-132 + baﬁlomycin A1 did not signiﬁcantly increase the concentra-
tion of mature IL-1β in cell lysates when compared to controls.Fig. 10. Summary of the signaling induced byMG-132+ baﬁlomycin A1 in ARPE-19 cells.
Inhibition of intracellular degradation induces a slight production of HNE and an accumu-
lation of protein aggregates. The NLRP3 inﬂammasomes become activated and start to
produce IL-1β but not IL-18. IL-1β already at a concentration as low as 1 pg/ml is able to
upregulate signiﬁcantly the production of IL-8.
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4-hydroxynonenal (HNE) is capable of inducing inﬂammasome signal-
ing in ARPE-19 cells [18]. After exposure to 30 μM HNE, the cells also
produced over 100 pg/ml IL-18, whereas in the present study, MG-
132 + baﬁlomycin A1 treatment stimulated the release of IL-1β but
not that of IL-18. As an interesting detail, we observed that MG-132 ex-
posure was able to induce intracellular HNE-protein adduct formation
in ARPE-19 cells. Since the levels of HNE-protein adducts induced by
MG-132were about four-fold lower than those induced by our previous
HNE exposure (30 μM), we hypothesized that lower concentrations of
endogenous HNE could speciﬁcally prefer the production of IL-1β.
When we exposed our cells to different HNE concentrations, the results
indeed supported the proposal that low amounts of HNE tend to release
preferentially IL-1β.
HNE is a major marker of oxidative stress in retina and also an in-
triguingmolecule. At low concentrations, it is known to promote prolif-
eration and cell survival, whereas at high concentrations it acts in the
opposite way [32–34]. Especially when one considers the situation in
AMD, it is very interesting that HNE also regulates the VEGF production
in a concentration-dependentmanner. It has been shown that low HNE
concentrations (b5 μM) trigger VEGF release in human ARPE-19 and
RPE-28 cells, whereas concentrations higher than 5 μM reduce its re-
lease [32,34]. VEGF secreted by RPE cells also exhibits true angiogenic
potential as demonstrated by HUVEC cells that displayed increased
migration and tube formation in matrigel when grown with a culture
medium fromRPE cells treatedwith 1 μMHNE [34]. Therefore, our pres-
ent results showing that lowHNE concentrations lead to the production
of IL-1β are in line with the previous studies mentioned above since
IL-1β is known to promote VEGF production [35]. Interestingly, it was
recently shown that blocking the NLRP3 or IL-1β signaling resulted in
reduced RPE barrier breakdown and neovascularization in mice [36].
The ﬁnding suggests that NLRP3 inﬂammasome activation with IL-1β
secretion can contribute to the pathogenesis of wet AMD. Tarallo et al.,
in turn, have recently demonstrated that there is an association be-
tween IL-18 release and geographic atrophy [19]. The detailed role of
this polarization in the pathogenesis of AMD needs to be elucidated in
further studies.
Our present data demonstrate that degenerated intracellular clear-
ance is associated with the induction of inﬂammation through an intra-
cellular danger sensor system. Concurrent treatment with MG-132 and
baﬁlomycin A1 also induced intracellular production of HNE providing
evidence that declined degradation, oxidative stress, and inﬂammation
play a role in disturbing the functionality of RPE cells. Our data also
showed that already low concentrations (1 pg/ml) of IL-1β are able to
induce a secondary response by promoting the production of IL-8,
which is amajor chemotacticmediator of human RPE attracting neutro-
phils and monocytes [37]. Although IL-1β levels produced by the MG-
132 + baﬁlomycin A treatment remained lower than 1 pg/ml, a pre-
treatment of cells with LPS increased the production to 1–3 pg/ml and
therefore, IL-1β at 1 pg/ml was chosen for a stimulatory concentration.
LPS activates nuclear factor kappa B (NF-κB) signaling, which can
become activated in vivo in RPE cells e.g. by fragments of extracellular
matrix or stress-related alarmins, such as HSP60 and HMGB1 [38,39].
NF-κB signaling is a major pathway in mediating the inﬂammasome
priming but in our experimental settings, it becomes inhibited by MG-
132 [40,41]. It is known that IL-1β is also able to stimulate the produc-
tion of IL-6 in ARPE-19 cells [42]. However, since the production of IL-6
could not be detected in the cell cultures directly releasing IL-1β due to
the inhibitory effect of MG-132 on its major regulator NF-κB [43], the
contribution of IL-6 has been omitted from the present analysis. Further
studies are naturally needed for verifying the link between the
inﬂammasome activation and leukocyte chemotaxis but it seems possi-
ble that age-related decline in intracellular cleaning systems with the
subsequent production of IL-1β has even broader biological signiﬁcance
than shown in this study. However, our data indicate thatmalfunctional
clearance can result in the inﬂammasome activation in human RPE cells.Acknowledgments
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